From: Corifollitropin alfa for poor responders patients, a prospective randomized study
Control | Long agonist CFA | Antagonist CFA | |
---|---|---|---|
Retrieved oocytes | 3,6 + 2,2 | 5,5 + 2,3* | 4,8 + 2,1* |
N of MII oocytes | 2,1 + 1,6 | 3,7 + 1,7* | 3,4 + 1,5* |
N of Embryos | 1,8 + 0,8 | 2,9 + 0,5* | 2,5 + 0,6* |
N of no transfer | 13/136 (9,5%) | 6/137 (4,3%)** | 9/136 (6,6%)* |
Pregnancies/transfer | 18/123 (14,6%) | 26/131 (19,8%)* | 21/127 (16,5%) |
Ongoing pregnancies/transfer | 13/123 (10,5%) | 21/131 (16,1%)* | 17/127 (13,4%) |
Ongoing pregnancies/ITT | 13/136 (9,5%) | 21/137 (15,3%)* | 17/136 (12,5%) |